Add this topic to your myFT Digest for news straight to your inbox
St Mary’s in London is an example of how a longtime lack of spending is being felt across the system
Expert say altering standards alone will not be enough to improve vital services
Game-like programme encouraged heavy drinkers to consume as much as 10% less, say researchers
Successful study advances prospects of xenotransplantation, using engineered organs from animals
Health department to spend £210mn to track deadly superbugs across Asia and Africa
‘Another Brick in the Wall’ study could help people with severe neurological damage to communicate
A Hungarian doctor and Donald Trump show why it’s important to get your message across clearly at work
US pharmaceutical group says it wants to become the first trillion dollar healthcare company
Number of deals in sector hits highest level in a decade despite wider M&A slowdown
Straight-talking solutions to tricky workplace dilemmas, from the host of the Working It podcast
A new study bolsters the case that semaglutide is not merely a vanity drug but has a key role to play in treating obesity
Americans have bet $245bn on sporting events since restrictions were loosened in 2018. But many fear a surge in gambling addiction is coming
Government urged to act to prepare hospitals and care homes for higher temperatures as FT analysis reveals regional vulnerabilities
Drugs that tackle obesity, diabetes and heart disease are good for profits and the public
Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug
Research finds superbugs increase in tandem with levels of small particulate matter in the air
New vaccines centre supports aim to develop jab for any new potential killer pathogen within 100 days
But with two Netflix shows and a retrospective photobook on the way, the actor, bodybuilder and politician is forcing himself to be reflective
Partnership with private sector aimed at cutting waiting lists amid spending constraints
Scientists hail ‘entirely novel approach’ to controlling a disease that kills more than 600,000 a year
Legal and regulatory actions are more likely to drag on earnings than negate them
Novo Nordisk and Eli Lilly accused of failing to warn patients of gastroparesis risk
Chemify’s technology aims to remove bottleneck of producing molecules in the lab
Tadeu Marroco admits there are issues such as underage use as many countries adopt tougher stance on e-cigarettes
What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon. Also: counting the cost of rising long-term sickness on the economy; how organisations can tackle rising levels of exhaustion and retain staff; workspace designers are going all out on domesticity
UK Edition
